274 related articles for article (PubMed ID: 15620516)
1. The sacred cow: the questionable role of assay methods in characterising the quality of bulk pharmaceuticals.
Görög S
J Pharm Biomed Anal; 2005 Jan; 36(5):931-7. PubMed ID: 15620516
[TBL] [Abstract][Full Text] [Related]
2. Drug safety, drug quality, drug analysis.
Görög S
J Pharm Biomed Anal; 2008 Sep; 48(2):247-53. PubMed ID: 18082992
[TBL] [Abstract][Full Text] [Related]
3. Impurity profiling of pharmaceuticals by thin-layer chromatography.
Ferenczi-Fodor K; Végh Z; Renger B
J Chromatogr A; 2011 May; 1218(19):2722-31. PubMed ID: 21255781
[TBL] [Abstract][Full Text] [Related]
4. Some considerations regarding drug determinations in biological fluids with physico-chemical methodologies [proceedings].
De Graeve J
Ann Biol Clin (Paris); 1978; 36(3):161-8. PubMed ID: 360889
[No Abstract] [Full Text] [Related]
5. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
Skrdla PJ; Wang T; Antonucci V; Dowling T; Ge Z; Ellison D; Curran J; Mohan G; Wyvratt J
J Pharm Biomed Anal; 2009 Dec; 50(5):794-6. PubMed ID: 19596534
[TBL] [Abstract][Full Text] [Related]
6. Determination of phenothiazine derivatives by high performance thin-layer chromatography combined with densitometry.
Wójciak-Kosior M; Skalska A; Matysik A
J Pharm Biomed Anal; 2006 Apr; 41(1):286-9. PubMed ID: 16321493
[TBL] [Abstract][Full Text] [Related]
7. A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materials.
Gavin PF; Olsen BA; Wirth DD; Lorenz KT
J Pharm Biomed Anal; 2006 Jun; 41(4):1251-9. PubMed ID: 16621411
[TBL] [Abstract][Full Text] [Related]
8. Elimination of autosampler carryover in a bioanalytical HPLC-MS/MS method: a case study.
Vallano PT; Shugarts SB; Woolf EJ; Matuszewski BK
J Pharm Biomed Anal; 2005 Jan; 36(5):1073-8. PubMed ID: 15620534
[TBL] [Abstract][Full Text] [Related]
9. Accuracy profiles assessing the validity for routine use of high-performance thin-layer chromatographic assays for drug formulations.
Shewiyo DH; Kaale E; Risha PG; Dejaegher B; De Beer J; Smeyers-Verbeke J; Vander Heyden Y
J Chromatogr A; 2013 Jun; 1293():159-69. PubMed ID: 23639129
[TBL] [Abstract][Full Text] [Related]
10. Effect of incomplete removal of the tert-butoxycarbonyl protecting group during synthesis of a pharmaceutical drug substance on the residual solvent analysis.
Beilin E; Baker LJ; Aikins J; Baryla NE
J Pharm Biomed Anal; 2010 Jun; 52(2):316-9. PubMed ID: 20116957
[TBL] [Abstract][Full Text] [Related]
11. Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).
Borman PJ; Chatfield MJ; Crowley EL; Eckers C; Elder DP; Francey SW; Laures AM; Wolff JC
J Pharm Biomed Anal; 2008 Dec; 48(4):1082-9. PubMed ID: 18835674
[TBL] [Abstract][Full Text] [Related]
12. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
Carrier D; Eckers C; Arnoult T; Thurston T; Major H
Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
[No Abstract] [Full Text] [Related]
13. LC-MS characterization of trace impurities contained in calcium folinate.
Francese G; Corana F; Meneghetti O; Marazza F
J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug product.
Liu C; Dong S; Xu XJ; Yin Y; Shriver Z; Capila I; Myette J; Venkataraman G
J Pharm Biomed Anal; 2011 Jan; 54(1):27-36. PubMed ID: 20800406
[TBL] [Abstract][Full Text] [Related]
15. Improving method capability of a drug substance HPLC assay.
Dejaegher B; Jimidar M; De Smet M; Cockaerts P; Smeyers-Verbeke J; Vander Heyden Y
J Pharm Biomed Anal; 2006 Sep; 42(2):155-70. PubMed ID: 16621413
[TBL] [Abstract][Full Text] [Related]
16. Quality evaluation of chloroquine, quinine, sulfadoxine-pyrimethamine and proguanil formulations sold on the market in East Congo DR.
Atemnkeng MA; Chimanuka B; Plaizier-Vercammen J
J Clin Pharm Ther; 2007 Apr; 32(2):123-32. PubMed ID: 17381662
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of high performance liquid chromatography method for analysis of sibutramine hydrochloride and its impurity.
Chandorkar JG; Kotwal VB; Dhande NS; Pachpor MP; Pande VV
Pak J Pharm Sci; 2008 Apr; 21(2):121-4. PubMed ID: 18390441
[TBL] [Abstract][Full Text] [Related]
18. Validation of thin layer and high performance thin layer chromatographic methods.
Renger B; Végh Z; Ferenczi-Fodor K
J Chromatogr A; 2011 May; 1218(19):2712-21. PubMed ID: 21329932
[TBL] [Abstract][Full Text] [Related]
19. Quantitative determination of L-DOPA in tablets by high performance thin layer chromatography.
Mennickent S; Nail M; Vega M; de Diego M
J Sep Sci; 2007 Aug; 30(12):1893-8. PubMed ID: 17638351
[TBL] [Abstract][Full Text] [Related]
20. HPTLC methods to assay active ingredients in pharmaceutical formulations: a review of the method development and validation steps.
Shewiyo DH; Kaale E; Risha PG; Dejaegher B; Smeyers-Verbeke J; Vander Heyden Y
J Pharm Biomed Anal; 2012 Jul; 66():11-23. PubMed ID: 22494517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
